Ipca Laboratories Ltd. benchmarking: Perfomance to industry peers

Financial

	Ipca Laboratories	Ajanta Pharma	Glaxosmithkline Phar
Operational Metrics
Pharmaceuticals
Number of ANDA's Filed in USA	44.0 .	78.0 .	n/a
Number of ANDA's Approved By USFDA	31.0 .	56.0 .	n/a
Domestic Sales Growth - YoY	8.3 %	7.5 %	7.8 %
US DMF Filings	55.0 .	n/a	n/a
R&D as a % of Total Sales	3.12 %	5.0 %	0.07 %
Financials
5 yr Average ROE	13.55 %	21.63 %	40.73 %
5yr average Equity Multiplier	1.52	1.32	1.9
5yr Average Asset Turnover Ratio	0.76	0.84	0.94
5yr Avg Net Profit Margin	11.88 %	19.77 %	24.91 %
Price to Book	4.98	7.64	25.23
P/E	44.51	33.86	45.1
5yr Avg Cash Conversion Cycle	54.3 Days	-102.34 Days	-107.65 Days
Inventory Days	102.83 Days	55.16 Days	51.6 Days
Days Receivable	72.68 Days	49.8 Days	22.78 Days
Days Payable	111.38 Days	195.69 Days	144.46 Days
5yr Average Interest Coverage Ratio	50.79	108.5	479.64
5yr Avg ROCE	17.31 %	27.48 %	44.44 %
5yr Avg Operating Profit Margin	19.8 %	27.65 %	25.23 %
5 yr average Debt to Equity	0.17	0.0	0.0
5yr CAGR Net Profit	-8.34 %	7.08 %	20.96 %
5yr Average Return on Assets	9.41 %	16.51 %	21.84 %
Shareholdings
Promoter Holding	44.72 %	66.25 %	75.0 %
Share Pledged by Promoters	0.0	15.28 %	0.0
Change in Promoter Holding (3 Yrs)	-1.57 %	-4.23 %	0.0
Change in Mutual Fund Holding (3 Yrs)	0.33 %	3.53 %	1.23 %

Business

	Ipca Laboratories	Ajanta Pharma	Glaxosmithkline Phar
Product Wise Break-Up	Product Wise Break-Up Branded Generics 50.39 Formulations 33.08 Active Pharmaceutical Ingredient (API) 16.53 Pharmaceutical products 0 Vaccines 0 Pharmaceuticals 0	Product Wise Break-Up Active Pharmaceutical Ingredient (API) 0 Pharmaceutical 100.0 Branded Generics 0 Pharmaceuticals 0 Formulations 0 Vaccines 0	Product Wise Break-Up Active Pharmaceutical Ingredient (API) 0 Pharmaceutical products 0 Branded Generics 0 Pharmaceutical 76.0 Formulations 0 Vaccines 24.0
Therapeutic Area Wise Break-Up - Domestic	Therapeutic Area Wise Break-Up - Domestic Pain 53.0 Cardiac Science 17.0 Dermatology 6.0 Urology 5.0 Anti-bacterial 5.0 Cough and colds 4.0 Central Nervous System (CNS) 3.0 Anti Malarials 3.0 Gastro Intestinal 2.0 Neutraceuticals 1.0 0 Respiratory 0 Hormones 0 Pain/Analgesics 0 Vaccines 0 Anti-Infectives 0 Vitamins/Minerals/Nutrients 0 Others 1.0	Therapeutic Area Wise Break-Up - Domestic Pain 10.0 Gastro Intestinal 0 Neutraceuticals 0 Anti-bacterial 0 Central Nervous System (CNS) 0 Pain/Analgesics 0 Cardiac Science 0 Cough and colds 0 Anti Malarials 0 Hormones 0 Anti-Infectives 0 Vitamins/Minerals/Nutrients 0 Vaccines 0 0 Dermatology 23.0 Respiratory 0 Urology 0 Others 67.0	Therapeutic Area Wise Break-Up - Domestic Pain 0 Gastro Intestinal 0 Neutraceuticals 0 Anti-bacterial 0 Central Nervous System (CNS) 0 Pain Management 11.96 Cardiac Science 0 Cough and colds 0 Anti Malarials 0 Hormones 8.91 Anti-Infective 22.25 Vitamins / Minerals / Nutrients 6.47 Vaccines 12.64 0 Dermatology 30.55 Respiratory 3.95 Urology 0 Others 3.27
Location Wise Break-Up	Location Wise Break-Up India 44.73 USA 21.58 Europe 15.68 Africa 6.72 Asia Pacific 5.18 Australia 3.2 CIS 2.91 Asia 0 Rest of the World 0	Location Wise Break-Up Africa 18.89 CIS 0 Asia Pacific 0 Asia Pacific 23.15 Rest of the World 0 USA 25.69 Europe 0 Australia 0 India 32.26 Others 0.01	Location Wise Break-Up Africa 0 CIS 0 Asia Pacific 0 Asia 0 Rest of the World 1.35 USA 0 Europe 0 Australia 0 India 98.65
Therapeutic Area Break-Up	Therapeutic Area Break-Up Cardiovascular & Anti Diabetics 25.0 Anti Malarials 24.0 NSAID 21.0 Neuro 7.0 GI 6.0 Cough 2.0 Nutraceuticals 0 Urology 0 Dermatology 0 Others 15.0	-	-

Ipca Laboratories Ltd.

Ipca Laboratories Ltd.

Financial

Business

SIGN UP FOR FREE